Literature DB >> 12781475

Evaluation of antigen and antibody rapid detection tests for Trypanosoma evansi infection in camels in Kenya.

J M Ngaira1, B Bett, S M Karanja, E N M Njagi.   

Abstract

The card agglutination test for Trypanosoma evansi (CATT/T. evansi) for the detection of antibodies, and Suratex for the detection of circulating antigens were compared in a cross-sectional study involving camels in eastern and central parts of Kenya. Of the 2227 camels screened, 2038 were owned by nomadic pastoralists in T. evansi endemic areas in eastern Kenya. A herd of 86 camels were from a ranch in Mugwoni. In Athi River area, 35 camels belonged to Kenya Trypanosomiasis Research Institute, and 68 were slaughter animals. Diagnostic sensitivity estimates were obtained by testing sera from 51 camels that had been found to be parasitologically positive by the haematocrit centrifugation technique, buffy-coat technique and mouse inoculation. Diagnostic specificity was estimated by testing sera from 35 camels known to be trypanosome-free. Positive and negative predictive values (NPVs) were calculated using a range of prevalence values. The sensitivity of CATT/T. evansi (68.6%) was higher than that of Suratex (58.8%), but not significantly. Both tests had equally high specificity (100%). The overall prevalence was 2.3% (51 out of 2227) by parasite detection, 32.2% (327 out of 1017) by CATT/T. evansi and 19.6% (188 out of 961) by Suratex. Overall, there was a positive association between CATT/T. evansi and Suratex though the strength of association was low (McNemar's test=46.12, P=0.001; kappa=0.26, CI: 0.20-0.33). Parasite prevalence ranged from 0% in several herds to 27.8% in a herd in Isiolo. Prevalence was highest in Isiolo with 2.5% (51 out of 2030) by parasitological detection, 38.8% (321 out of 828) by CATT/T. evansi and 21.9% (169 out of 772) by Suratex. In Mugwoni prevalence was 7 and 18% by CATT/T. evansi and Suratex, respectively, and no parasites were detected. In Athi River Suratex detected 2.9% (3 out of 103) positive while CATT/T. evansi and parasitological methods gave negative results. At prevalence values between 10 and 100%, CATT/T. evansi as well as Suratex had infinitely high positive predictive values, whereas Suratex had a lower NPV than CATT/T. evansi. In conclusion, results of this study showed that CATT/T. evansi and Suratex were able to detect aparasitaemic infections rapidly and were more sensitive than parasitological methods in revealing the true extent of trypanosomosis in a herd. The tests effectively complemented parasitological methods in the detection of T. evansi infections in camels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781475     DOI: 10.1016/s0304-4017(03)00112-2

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  11 in total

1.  Estimating the economic impact of Trypanosoma evansi infection on production of camel herds in Somaliland.

Authors:  Abdirahman Abdikadir Salah; Ian Robertson; Abdullahi Mohamed
Journal:  Trop Anim Health Prod       Date:  2015-02-28       Impact factor: 1.559

2.  Differential virulence of camel Trypanosoma evansi isolates in mice.

Authors:  Christine M Kamidi; Joanna Auma; Paul O Mireji; Kariuki Ndungu; Rosemary Bateta; Richard Kurgat; Collins Ouma; Serap Aksoy; Grace Murilla
Journal:  Parasitology       Date:  2018-01-24       Impact factor: 3.234

3.  Tandem repeat protein as potential diagnostic antigen for Trypanosoma evansi infection.

Authors:  Nguyen Thu Thuy; Yasuyuki Goto; Zhao-Rong Lun; Shin-Ichiro Kawazu; Noboru Inoue
Journal:  Parasitol Res       Date:  2011-09-17       Impact factor: 2.289

4.  Prevalence and distribution of Trypanosoma evansi in camels in Somaliland.

Authors:  A A Salah; I D Robertson; A Sh Mohamed
Journal:  Trop Anim Health Prod       Date:  2019-06-08       Impact factor: 1.893

5.  Towards a new reference test for surra in camels.

Authors:  Thao Tran; Filip Claes; Didier Verloo; Henri De Greve; Philippe Büscher
Journal:  Clin Vaccine Immunol       Date:  2009-04-29

6.  Multiple evolutionary origins of Trypanosoma evansi in Kenya.

Authors:  Christine M Kamidi; Norah P Saarman; Kirstin Dion; Paul O Mireji; Collins Ouma; Grace Murilla; Serap Aksoy; Achim Schnaufer; Adalgisa Caccone
Journal:  PLoS Negl Trop Dis       Date:  2017-09-07

7.  An Unbiased Immunization Strategy Results in the Identification of Enolase as a Potential Marker for Nanobody-Based Detection of Trypanosoma evansi.

Authors:  Zeng Li; Joar Esteban Pinto Torres; Julie Goossens; Didier Vertommen; Guy Caljon; Yann G-J Sterckx; Stefan Magez
Journal:  Vaccines (Basel)       Date:  2020-07-24

8.  Seroprevalence and risk factors for Trypanosoma evansi, the causative agent of surra, in the dromedary camel (Camelus dromedarius) population in Southeastern Algeria.

Authors:  Mohammed H Benaissa; Nora Mimoune; Younes Bentria; Tahar Kernif; Abdelaziz Boukhelkhal; Curtis R Youngs; Rachid Kaidi; Bernard Faye; Youcef Halis
Journal:  Onderstepoort J Vet Res       Date:  2020-12-21       Impact factor: 1.792

9.  Parasitological, serological and molecular survey of Trypanosoma evansi infection in dromedary camels from Cholistan Desert, Pakistan.

Authors:  Sonia Tehseen; Nusrat Jahan; Muhammad Fiaz Qamar; Marc Desquesnes; Mirza Imran Shahzad; Stijn Deborggraeve; Philippe Büscher
Journal:  Parasit Vectors       Date:  2015-08-12       Impact factor: 3.876

10.  Systematic review and meta-analysis on the global distribution, host range, and prevalence of Trypanosoma evansi.

Authors:  Weldegebrial G Aregawi; Getahun E Agga; Reta D Abdi; Philippe Büscher
Journal:  Parasit Vectors       Date:  2019-01-31       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.